Although it seems that MC4R agonists have a small remit in the treatment of rare genetic causes of obesity, gaining a better understanding of the genetics of severe obesity has helped unveil the importance of the melanocortin pathway in appetitive control, and may pave the way for new avenues of obesity pharmacotherapy in the future. This evidence concerns the gene MC4R and obesity due to melanocortin 4 receptor deficiency.